Bill
HB 1641
Addressing public health challenges of high-potency cannabis products.
2023-2024 Regular Session
Introduced by Lisa Callan and 11 co-sponsors
Expands JCARR's authority to review agency rules, guidance, and non-rule actions, compel documents and testimony, and sanction noncompliance to boost legislative oversight.
By resolution, reintroduced and retained in present status.